Nanōmix is a leader in decentralized testing and a participant in the large, fast-growing Point of Care (POC) diagnostics market. Their market-ready Critical Infection Panel is the only portable, rapid PCT assay and allows for obtaining critical information more quickly, leading to faster clinical decision-making.
IR Website: https://ir.nanomixdx.com/
Headquarters: San Leandro, CA
Nanōmix has invested heavily into IP with all technology developed and wholly owned by the company, including 23 issued and pending patents. As a result they are moving towards a robust and connected future of one instrument with lab quality results for many different tests.
Last updated: 1/10/23
TALK TO MANAGEMENT
The Nanōmix management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.
Stock Chart (Intraday)
Stock Chart (Historical)
Video: The Nanōmix Vision
Video: An Introduction to Nanōmix with Board Member and ex-CEO David Ludvigson
Video: Diving Deeper Into The Company Itself
Disrupting the Place and Time of Quality Diagnostics, Better Outcomes
Accessibility to the Quality of Our Technology
Platform Technology, Designed for Rapid Menu Expansion
Addressing Major Market Needs
The Point-of-Care (PoC) Industry
Nanōmix's Intellectual Property and Regulatory Clearance
Risks & Disclosures
The Nanomix management and investor relations team is available to talk to current and potential investors. They're happy to answer your questions and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.
• Directly hear the Nanomix story
• Ask your questions
• Submit the form below and someone will get in touch with you as soon as possible
Note: Company management or its representative can only discuss and disclose information that is already available in the public domain. They will do their best to clarify such information to the extent permitted by securities law and industry regulations.